Glaxo Wellcome Advair Diskus
Executive Summary
FDA Pulmonary & Allergy Drugs Advisory Committee meeting to review Glaxo's salmeterol/fluticasone inhaled powder formulation will be held at the Holiday Inn in Bethesda, Md. (1"The Pink Sheet" Oct. 11, In Brief)You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
Shire Hopes To Sow Future Deals With $50M Venture Fund
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: